This inventor holds 71 USPTO granted patents and 31 published patent applications, plus 2 CIPO patents and 15 EPO patents, primarily in Inflammation Therapeutics (CPC class C07D). Top assignees: Synta Pharmaceuticals Corporation, Kava Pharmaceuticals, Inc., Madrigal Pharmaceuticals, Inc.. Active years: 2004-2020.
Inventors with similar research interests:
Location History:
- Billerica, MA (US) (2004 - 2010)
- Bedford, MA (US) (2005 - 2020)
Company Filing History:
66 out of 162 
1 out of 3 
1 out of 28 
Years Active: 2004-2020
Areas of Expertise:
Title: The Innovations and Contributions of Shoujun Chen
Introduction
Shoujun Chen, based in Bedford, MA, is a prolific inventor with an impressive portfolio of 71 patents. His innovative work primarily focuses on pharmacological compounds, targeting therapeutics, and immunosuppressive agents, contributing significantly to the fields of medicine and biotechnology.
Latest Patents
Among his latest inventions are groundbreaking pharmacological compounds that include an effector moiety conjugated to a binding moiety, aimed at directing therapeutic agents to specific biological targets. These compounds, known as Protein Interacting Binding Moiety-Drug Conjugate (SDC-TRAP) compounds, exemplify advancements in cancer treatment, particularly through the use of Hsp90 inhibitors linked to cytotoxic agents. Additionally, he has developed compounds useful in treating inflammatory and immune-related conditions, offering new solutions as immunosuppressive agents and for managing various allergic disorders.
Career Highlights
Shoujun Chen's career has been marked by his significant tenure at Synta Pharmaceuticals Corporation, where he played a vital role in the development of innovative medicinal products. His extensive experience has solidified his reputation as a leading researcher and inventor in pharmacology.
Collaborations
Throughout his career, Chen has collaborated with several noted professionals, including Lijun Sun and Keizo Koya. These partnerships have fostered an environment of innovation and have been integral to the development of his patent portfolio.
Conclusion
Shoujun Chen's contributions to the field of pharmacology and medicine through his various patents demonstrate his commitment to advancing healthcare solutions. His innovative therapies for cancer and inflammatory conditions reflect his dedication to improving patient outcomes and enhancing medical practices.